However, several pathological conditions occurring in the course of diabetes upregulate the expression of VEGF (Behl and Kotwani, 2015; Kida et al., 2021), which therefore may lead to increased endothelium permeability, decreased inhibition of pro-apoptotic proteins, activation of various inflammatory mediators, and ultimately neoangiogenesis. Here, VEGFA is linked to diabetes mellitus.